Below are MBC trials that have been added to BreastCancerTrials.org (BCT) in the last month. These trials can also be found on Metastatic Trial Search (MTS)
All MBC
Triple-Negative
- ABBV-927 and ABBV-368 for Advanced Triple Negative Breast Cancer
- Avelumab With Binimetinib, Utomilumab, or PF-04518600 For Advanced Triple Negative Breast Cancer
- Capivasertib & Paclitaxel as First-Line Treatment for Advanced Triple Negative Tumors
- Estradiol in Advanced Triple Negative Tumors that Test Positive for ER Beta
- Immunotherapy INCAGN02385 in Advanced Triple Negative Breast Cancer
- Immunotherapy DKY709 Alone or With PDR001 in Advanced Triple Negative Breast Cancer
- LY3023414 Followed by Prexasertib in Metastatic Triple Negative Breast Cancer
- TPST-1120 Alone or With a Systemic Therapy in Advanced Triple Negative Breast Cancer
- TT-00420 For Advanced Triple Negative Breast Cancer
HER2 Positive (HER2+)
Others
Use Metastatic Trial Search to find all metastatic breast cancer trials that are right for you.
Last Modified on August 25, 2020